title: Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.
authors.affiliation: Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela jaurbina@mac.com.
authors.forename: Julio A
authors.initials: JA
authors.lastname: Urbina
authors.affiliation: Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD, San Diego, California, USA.
authors.forename: James H
authors.initials: JH
authors.lastname: McKerrow
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D014355:Chagas Disease / Q000188:drug therapy*; D002908:Chronic Disease / Q000188:drug therapy*; D005260:Female; D014230:Triazoles / Q000494:pharmacology*; D014344:Trypanocidal Agents / Q000494:pharmacology*; D014349:Trypanosoma cruzi / Q000187:drug effects*
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; D014344:Trypanocidal Agents